Prescription Inhalation Powder Recalled for Storage Temperature Deviation
Cardinal Healthcare recalls batch 62002532 of Wixela Inhub inhalation powder nationwide due to CGMP deviations. Products were exposed to temperatures outside labeled storage conditions, potentially affecting product stability.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II manufacturing deviation involving temperature exposure on a prescription respiratory medication. While no illnesses or injuries have been reported, temperature deviation may compromise drug stability and efficacy in a risk-of-harm product.
Plain-English summary
Cardinal Healthcare is recalling batch 62002532 of Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, 500/50 mcg) manufactured for Mylan Pharmaceuticals Inc. The recall is due to manufacturing (CGMP) deviations. Products in this batch were exposed to temperatures outside the labeled storage conditions.
Wixela Inhub is distributed nationwide as a prescription inhalation medication. Temperature exposure outside specified storage conditions may affect the stability and efficacy of the product.
Patients currently using this recalled batch should contact their healthcare provider or pharmacist. Do not discontinue use without medical guidance. Your healthcare provider can verify whether you have the affected batch and provide appropriate guidance or a replacement as needed.
The recalled product
- Product
- WIXELA INHUB (FLUTICASONE PROPIONATE AND SALMETEROL)
- Brand
- WIXELA INHUB
- Manufacturer
- CARDINAL HEALTHCARE
- Category
- Drug — Prescription Inhalation
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch 62002532
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 42 recalled by CARDINAL HEALTHCARE under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 42 products in this recall →Related recalls
Same manufacturer · CARDINAL HEALTHCARE
See all →- HighAlbuterol Sulfate Inhaler Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- ModerateMeloxicam 15 mg tablets recalled for exposure to improper storage temperatures
FDA (Drugs) · 2024-01-03
- HighPredniSONE Tablets Recalled for Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighLow-dose aspirin recall due to improper storage temperature conditions
FDA (Drugs) · 2024-01-03
- HighBumetanide Tablets Recalled for Exposure to Improper Storage Temperatures
FDA (Drugs) · 2024-01-03
Same hazard · storage temperature deviation
See all →- HighWarfarin Sodium Tablets Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighLansoprazole Suspension Recalled Due to Temperature Storage Deviations
FDA (Drugs) · 2024-01-03
- ModerateAlbuterol sulfate inhalation aerosol recalled for temperature storage deviation
FDA (Drugs) · 2024-01-03
- ModerateFDA recalls Asmanex asthma inhalation powder for improper storage conditions
FDA (Drugs) · 2024-01-03
- ModerateC. difficile diagnostic kit recalled due to storage temperature deviation
FDA (Devices) · 2023-01-11